Multimorbidity in Focus: Emerging Patterns, Medication Appropriateness and Clinical Innovation
Resumen: Chronic conditions and multimorbidity are significantly altering the landscape of modern clinical care. When we launched this Special Issue, our goal was to compile research that sheds light on these challenges from various perspectives, including clinical, epidemiological, methodological and patient-centred. This Special Issue provides insights into disease trajectories, medication safety, vulnerable populations and emerging tools to understand and address multimorbidity, such as artificial intelligence (AI). We are grateful to all the contributing authors, the reviewers who enhanced the manuscripts and the editorial team of the Journal of Clinical Medicine for their support in this endeavour. Recent advancements in medicine and technology have improved the survival and management of chronic conditions. Multimorbidity has now become a common clinical concern among adults of all ages, from the young population to people over 100 [1,2,3,4]. This epidemiological shift poses significant challenges for healthcare providers and national health and social care systems, where clinical guidelines mainly focus on single diseases, failing to consider a person-centred approach in the management of people with multiple chronic conditions. The contributions in this Special Issue collectively underline that multimorbidity is not a static construct but a dynamic process that evolves across life stages, involves clinical and pharmacological interactions, and requires a re-engineering of current models of care
Idioma: Inglés
DOI: 10.3390/jcm15010101
Año: 2025
Publicado en: Journal of Clinical Medicine 15, 1 (2025), 101 [6 pp.]
ISSN: 2077-0383

Tipo y forma: Artículo (Versión definitiva)
Área (Departamento): Área Farmacología (Dpto. Farmac.Fisiol.y Med.L.F.)

Creative Commons Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace.


Exportado de SIDERAL (2026-01-07-18:53:46)


Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Artículos > Artículos por área > Farmacología



 Registro creado el 2026-01-07, última modificación el 2026-01-07


Versión publicada:
 PDF
Valore este documento:

Rate this document:
1
2
3
 
(Sin ninguna reseña)